DRW Securities’s Amicus Therapeutics FOLD Stock Holding History

DRW Securities’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70,670	Closed	-$1.02M	–	1140
2026 Q1	$1.02M	Buy	70,670 +49,670	+237%	+$712K	0.01%	330
2025 Q4	$299K	Sell	21,000 -20,027	-49%	-$197K	0.01%	679
2025 Q3	$318K	Sell	41,027 -52,360	-56%	-$373K	0.01%	812
2025 Q2	$535K	Buy	+93,387	New	+$603K	0.01%	470
2014 Q1	–	Sell	-33,593	Closed	-$79K	–	161
2013 Q4	$79K	Buy	+33,593	New	+$73.7K	﹤0.01%	212

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

DRW Securities's FOLD Position: Q2 2026 in Review

DRW Securities sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 70,670 shares — an estimated $1.02M sold.

DRW Securities first reported a position in FOLD in Q4 2013 and held it in 5 quarters. The position peaked at $1.02M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

DRW Securities reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 70,670 Amicus Therapeutics shares in Q2 2026, an estimated $1.02M.
DRW Securities first reported a position in Amicus Therapeutics in Q4 2013 and held it in 5 quarters.
DRW Securities's Amicus Therapeutics position peaked at $1.02M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.